CClinicalTrials.gg
CompletedNCT07306442Updated Dec 29, 2025

VR for Pain & Sleep in Burn Patients: A RCT

An interventional study of Virtual Reality Distraction and Standard Care in Burns, Pain and Sleep Disturbances, sponsored by Abadan University of Medical Sciences. Completed at 1 site in Iran. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-12-29.

Sponsored by Abadan University of Medical Sciences · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Jan 2025, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study aims to evaluate whether virtual reality (VR) can reduce pain and improve sleep quality during wound dressing changes in burn patients with 25-60% total body surface area (TBSA) burns, compared to standard care.

Read the detailed description

Background:

Burn injuries are extremely painful, especially during wound dressing changes. They also cause severe sleep problems, which can slow down healing. While medicines help, they often have side effects and don't fully solve these issues. Virtual reality (VR) is a new tool that distracts the brain from pain by immersing patients in a calming digital world. This study was designed to assess if VR could help with both pain and sleep in burn patients.

Methods:

We conducted a randomized controlled trial with 60 adult burn patients who had between 25% and 60% of their body burned. All patients were stable and able to understand instructions. We randomly assigned them into two groups: one group used VR headsets during their dressing changes, and the other group received standard care without VR. Pain was measured before and after the procedure using a simple 0-to-10 scale. Sleep quality was assessed using a standard questionnaire (PSQI) before and 24 hours after the treatment.

02

Conditions studied

  • Burns
  • Pain
  • Sleep Disturbances

Keywords

  • Virtual reality
  • Non-pharmacological intervention
  • Wound dressing
  • Tbsa
03

In context

Burns

719 studies on the registry are indexed under Burns; 145 are open to participants now.

This study's enrollment of 60 is above the median of 40 across 524 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

This is the only study on the registry with Abadan University of Medical Sciences as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • - Adult patients aged 18 to 60 years.
  • Deep partial-thickness or full-thickness burns covering 25% to 60% of total body surface area (TBSA).
  • Hemodynamic stability (systolic BP ≥90 mmHg, HR 60-100 bpm, no vasopressor use).
  • Ability to understand and comprehend Persian language.
  • Scheduled for at least one standardized, non-sedated wound dressing change procedure.

Exclusion criteria

Exclusion Criteria:

  • - Diagnosed psychiatric or neurological disorder (e.g., schizophrenia, epilepsy).
  • Severe visual impairment (best-corrected visual acuity \<20/200) or auditory impairment.
  • History of motion sickness or VR intolerance.
  • Contraindications to VR use (e.g., active vertigo, uncontrolled hypertension).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Virtual Reality Intervention Group

    Participants in this group received immersive virtual reality distraction during their wound dressing change procedure. They wore an Oculus Quest 2 headset and were immersed in a calming, interactive virtual environment (e.g., a peaceful beach or forest) for the duration of the dressing change (approximately 30-45 minutes). The audio was enabled to enhance immersion.

    Behavioral: Virtual Reality Distraction · Other: Standard Care

  • Placebo comparator
    Standard Care Group

    Participants in this group received standard care during their wound dressing change, which included verbal reassurance and routine analgesic administration as prescribed, without any additional distraction techniques such as virtual reality.

    Other: Standard Care

Interventions

  • BehavioralVirtual Reality Distraction

    Participants in the experimental group received immersive virtual reality distraction during their wound dressing change procedure. They wore an Oculus Quest 2 headset and were immersed in a calming, interactive virtual environment (e.g., a peaceful beach or forest) for the duration of the dressing change (approximately 30-45 minutes). The audio was enabled to enhance immersion. This intervention aimed to reduce procedural pain and improve sleep quality through cognitive distraction and relaxation.

    Also known as: VR Therapy

  • OtherStandard Care

    Participants in the control group received standard care during their wound dressing change, which included verbal reassurance and routine analgesic administration as prescribed, without any additional distraction techniques such as virtual reality. No specific intervention was administered beyond standard clinical practice.

    Also known as: Routine Burn Care

06

What researchers measure

Primary outcomes

  1. Change in Pittsburgh Sleep Quality Index (PSQI) Total Score

    The primary outcome for sleep quality was the change in the total score of the Pittsburgh Sleep Quality Index (PSQI) from baseline to 24 hours post-intervention. The PSQI is a validated self-report questionnaire assessing seven components of sleep quality over the past month. A higher score indicates poorer sleep quality. The change score (post-intervention minus pre-intervention) was calculated, with negative values indicating improvement.

    Time frame: 24 hours post-intervention

  2. Change in Visual Analog Scale (VAS) Pain Score

    The primary outcome for pain was the change in the Visual Analog Scale (VAS) score from immediately before to immediately after the wound dressing change procedure. The VAS is a 10-cm scale where 0 represents "no pain" and 10 represents "worst pain imaginable." The change score (post-procedure minus pre-procedure) was calculated, with negative values indicating pain reduction.

    Time frame: Immediately before and after the dressing change procedure

Secondary outcomes

  1. Change in individual components of the Pittsburgh Sleep Quality Index (PSQI)

    Secondary outcomes included changes in each of the seven individual components of the PSQI: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. These were assessed at baseline and 24 hours post-intervention.

    Time frame: 24 hours post-intervention

07

Study locations

1 site
  • Taleghani Burn and Trauma Hospital
    Ahvāz, Khuzestan, Iran
08

References and documents

Publications

  • Hoffman HG, Chambers GT, Meyer WJ 3rd, Arceneaux LL, Russell WJ, Seibel EJ, Richards TL, Sharar SR, Patterson DR. Virtual reality as an adjunctive non-pharmacologic analgesic for acute burn pain during medical procedures. Ann Behav Med. 2011 Apr;41(2):183-91. doi: 10.1007/s12160-010-9248-7. PubMed 21264690 ↗
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4. PubMed 2748771 ↗

Individual participant data

Plan to share: Yes — Yes, but only for specific purposes or under certain conditions Individual participant data (IPD) will be made available upon reasonable request to the corresponding author. Data sharing is subject to approval by the Ethics Committee of Abadan University of Medical Sciences and may require a formal data use agreement. Requests should include a detailed research proposal and must comply with local ethical and legal regulations.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07306442
Lead sponsor
Abadan University of Medical Sciences
Responsible party
Rasool Paygozar (PhD student in Health Sciences, Faculty Member, Abadan University of Medical Sciences, Abadan University of Medical Sciences) — Principal investigator
First posted
Dec 29, 2025
Start date
Jan 1, 2025
Primary completion
Jun 1, 2025
Completion
Jun 1, 2025
Last update
Dec 29, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion